Browse Immunosuppressive agents topic

Subtopics (12)

Articles

1-51 out of 51 article(s)

Title	Author	Type	Date	Words
Switzerland : Novartis launches generic immunosuppressant.			Aug 12, 2009	110
FDA requires labeling change for immunosuppressant drugs.			Aug 1, 2009	157
Blood to diagnose organ rejection.		Brief article	Jul 1, 2009	126
Postoperative panophthalmitis caused by whipple disease.	Drancourt, Michel; Fenollar, Florence; Denis, Daniele; Raoult, Didier	Report	May 1, 2009	1434
Immune research prevents transplant rejection.			May 1, 2009	140
End of the road for La Jolla? As a futility analysis derails BioMarin and LJP's Phase III Riquent trial, Trista Morrison, Bioworld.com, wonders if this is the end of Riquent and asks what the future holds for La Jolla Pharmaceuticals.	Morrison, Trista		May 1, 2009	821
La Jolla Pharma drops Riquent trial: negative results from an interim analysis of lupus drug Riquent were enough to shelve the late-stage drug that La Jolla Pharmaceutical had been developing.	Chambers, Heather	Brief article	Feb 23, 2009	151
Osiris, FDA reach agreement on submission of first marketing application for Prochymal.		Brief article	Feb 1, 2009	183
Scientists move a step closer to finding type 1 diabetes cure.			Jan 5, 2009	489
Scientists move a step closer to finding type 1 diabetes cure.			Jan 1, 2009	489
Factors associated with long-term survival following cardiac transplantation/Kalp nakli sonrasi uzun donem sagkalimi etkileyen faktorler.	Sareyyupoglu, Basar; Kirali, Kaan; Goksedef, Deniz; Rabus, Murat Bulent; Tuncer, Altug; Erentug, Ved		Oct 1, 2008	5361
Viral infection hope; In association with the NHS.			Aug 25, 2008	174
Argos Therapeutics Secures $35.2 Million Series C Financing.			Apr 23, 2008	374
Drug-Free Breakthrough for Transplant Patients.			Mar 1, 2008	292
Blood group wonder of liver transplant teenager; Demi-Lee Brennan: 'It's my second chance at life'.			Jan 26, 2008	686
Procedure gives new hope to transplant patients; Anti-rejection drugs not needed; Experts excited but cautious.		Clinical report	Jan 24, 2008	436
LifeCycle Pharma Initiates Phase II Clinical Trial for LCP-Tacro, an Immunosuppressant to Prevent Organ Rejection in Liver Transplant Recipients.			Dec 3, 2007	543
CD83.		Brief article	Sep 1, 2007	79
Siemens Medical Solutions Diagnostics Enters the Immunosuppressant Testing Market with the ADVIA Centaur Cyclosporine Assay.			Jul 19, 2007	663
Trends in therapeutic monitoring of immunosuppressive drugs.			Jul 1, 2007	687
Invasive cryptococcosis and adalimumab treatment.	Farinas, M. Carmen	Letter to the editor	Jun 1, 2007	1276
Argos Therapeutics Presents Immunosuppression Data for Soluble CD83 at the American Society of Transplantation Congress 2007.			May 4, 2007	511
Ceragenix Commences Second in Series of Clinical Trials.			Apr 25, 2007	1135
Argos Therapeutics Awarded U.S. Patent for CD83 Protein for Use in Immunological Disorders.			Mar 22, 2007	380
FDA approves new dosing recommendations for Wyeth's Rapamune in high immunologic risk renal transplant patients.			Mar 1, 2007	237
Weapon against MS: transplant drug limits nerve damage.	Seppa, N.		Sep 16, 2006	522
JDRF, Novocell form partnership to clinical test encapsulated human islets.		Brief article	Jun 16, 2006	151
Isotechnika receives additional United States patent for lead immunosuppressive drug, ISA247.			Jun 1, 2006	370
"I have a face like everyone else," transplant recipient tells the press.			Feb 13, 2006	396
Beneficial effect of immunosuppressive drugs on Parry-Romberg syndrome: a case report and review of the literature.	Uysal, Seval		Sep 1, 2005	1795
Oral pig worm therapy curbs Crohn's disease.	Jancin, Bruce		Apr 1, 2005	663
Novartis successfully completes European Mutual Recognition Procedure for new anti- rejection drug.		Brief Article	Feb 16, 2004	245
Experimental immunosuppressant shows promise of preventing organ rejection with fewer side effects.	Grygotis, Michele		Nov 15, 2003	629
Tolerogenic protocol reduces need for immunosuppression after lung transplant.			Jun 14, 2003	343
Organ recipients need support to take rejection meds.		Brief Article	May 14, 2003	231
Antibody therapy cuts risk of kidney rejection by 50%.		Brief Article	May 14, 2003	231
FDA gives Wyeth ok to withdraw cyclosporine from the Rapamune regimen of many kidney transplant recipients.		Brief Article	Apr 14, 2003	187
Novartis submits NDA to FDA for use of Certican for prevention of rejection following heart, kidney transplantation.		Brief Article	Dec 27, 2002	202
Full face transplants possible because of new immunosuppressive drug regimens.		Brief Article	Dec 9, 2002	181
Characteristics and outcomes of patients with Goodpasture's syndrome.	Hugghins, Stephanie Y.		Dec 1, 2002	6166
Tacrolimus better than cyclosporine for liver transplantation: UK study.		Brief Article	Nov 13, 2002	228
Cryptococcus neoformans Infection in Organ Transplant Recipients: Variables Influencing Clinical Characteristics and Outcome.	Singh, Nina	Statistical Data Included	May 1, 2001	6038
Nature Genetics publishes research validating Rigel's drug discovery technology as a powerful new approach to functional genomics.		Brief Article	Jan 1, 2001	685
Compugen applies for patent.		Brief Article	Dec 1, 2000	41
FDA GRANTS APPROVAL FOR GENERIC EQUIVALENT TO IMURAN.			Feb 1, 2000	188
Pancreas transplants: Are they a cure for diabetes?		Report	Oct 1, 1999	578
Aphton Corporation and Pasteur Merieux Connaught Form Strategic Alliance.			Feb 18, 1997	475
Terrapin's Oral Myelostimulant Demonstrates Significant Therapeutic Potential in Preclinical Studies: Accelerates Recovery of Bone Marrow and Increases Circulating Blood Cells After Their Suppression By Chemotherapeutic Agents.			Sep 28, 1995	612
THERAGENICS ENTERS AGREEMENT TO PURCHASE TWO ADDITIONAL CYCLOTRONS.			Jun 30, 1995	298
Why doesn't the body reject the fetus?	Silberner, Joanne		Aug 3, 1985	364
Living on borrowed legs.			Aug 3, 1985	298

Browse  Immunosuppressive agents topic

Subtopics (12)

Articles

Browse Immunosuppressive agents topic